Shanghai Jiao Tong University

About: Shanghai Jiao Tong University is a education organization based out in Shanghai, Shanghai, China. It is known for research contribution in the topics: Population & Cancer. The organization has 157524 authors who have published 184620 publications receiving 3451038 citations. The organization is also known as: Shanghai Communications University & Shanghai Jiaotong University.

High-efficiency small-molecule ternary solar cells with a hierarchical morphology enabled by synergizing fullerene and non-fullerene acceptors

Abstract: Using combinatory photoactive blends is a promising approach to achieve high power conversion efficiency in ternary organic photovoltaics However, the fundamental challenge of how to manipulate th

Polyhedral Oligosilsesquioxane‐Modified Boron Nitride Nanotube Based Epoxy Nanocomposites: An Ideal Dielectric Material with High Thermal Conductivity

Abstract: Dielectric polymer composites with high thermal conductivity are very promising for microelectronic packaging and thermal management application in new energy systems such as solar cells and light emitting diodes (LEDs). However, a well-known paradox is that conventional composites with high thermal conductivity usually suffer from the high dielectric constant and high dielectric loss, while on the other hand, composite materials with excellent dielectric properties usually possess low thermal conductivity. In this work, an ideal dielectric thermally conductive epoxy nanocomposite is successfully fabricated using polyhedral oligosilsesquioxane (POSS) functionalized boron nitride nanotubes (BNNTs) as fillers. The nanocomposites with 30 wt% fraction of POSS modified BNNTs exhibit much lower dielectric constant, dielectric loss tangent, and coefficient of thermal expansion in comparison with the pure epoxy resin. As an example, below 100 Hz, the dielectric loss of the nanocomposites with 20 and 30 wt% BNNTs is reduced by one order of magnitude in comparison with the pure epoxy resin. Moreover, the nanocomposites show a dramatic thermal conductivity enhancement of 1360% in comparison with the pristine epoxy resin at a BNNT loading fraction of 30 wt%. The merits of the designed composites are suggested to originate from the excellent intrinsic properties of embedded BNNTs, effective surface modification by POSS molecules, and carefully developed composite preparation methods.

Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections

Abstract: Unnecessary antibiotic use significantly contributes to increasing bacterial resistance, medical costs and the risk of drug-related adverse events. The blood marker procalcitonin increases in bacterial infections and decreases when patients recover from the infection. Hence, procalcitonin may be used to support clinical decision making for the initiation and discontinuation of antibiotic therapy in patients with a clinical suspicion of infection. Randomised controlled trials have demonstrated that such a strategy works, particularly in patients with an infection of the respiratory tract. However, most of these individual studies did not include enough patients to allow for a conclusive assessment about safety (low statistical power). Thus, the risk for mortality and severe complications associated with procalcitonin-guided decision making remained unclear. This systematic review included individual patient data from 14 randomised controlled trials with a total of 4211 participants. When looking at these combined data, we found no increased risk for all-cause mortality or treatment failure when procalcitonin was used to guide initiation and duration of antibiotic treatment in participants with acute respiratory infections compared to control participants. However, we found a consistent reduction of antibiotic use, mainly due to lower prescription rates in primary care and lower duration of antibiotic courses in emergency department and intensive care unit patients. This analysis is limited to adult patients with respiratory infections excluding patients who were immuno-compromised (i.e. HIV positive, those receiving immuno-suppressive therapies or chemotherapy). Most trials were conducted in Europe and China and similar studies in other countries including the United States are warranted.